ORASURE TECHNOLOGIES, INC Deferred Revenue, Revenue Recognized
ORASURE TECHNOLOGIES, INC (OSUR) reported Deferred Revenue, Revenue Recognized of $3.70 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-07.
Financial Statements › Income Statement › Other Income
us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2025-03-07
- ORASURE TECHNOLOGIES, INC deferred revenue, revenue recognized for the quarter ending 2024-09-30 was $500.00K, a 25.00% increase year-over-year.
- ORASURE TECHNOLOGIES, INC deferred revenue, revenue recognized for the quarter ending 2024-06-30 was $2.00M, a 122.22% increase year-over-year.
- ORASURE TECHNOLOGIES, INC deferred revenue, revenue recognized for the quarter ending 2024-03-31 was $700.00K, a 22.22% decline year-over-year.
- ORASURE TECHNOLOGIES, INC deferred revenue, revenue recognized for the quarter ending 2023-09-30 was $400.00K.
- ORASURE TECHNOLOGIES, INC deferred revenue, revenue recognized for fiscal 2024 was $3.70M, a 42.31% increase from fiscal 2023.
- ORASURE TECHNOLOGIES, INC deferred revenue, revenue recognized for fiscal 2023 was $2.60M.
| Period end | Deferred Revenue, Revenue Recognized 3 month | Deferred Revenue, Revenue Recognized 6 month | Deferred Revenue, Revenue Recognized 9 month | Deferred Revenue, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.70M 10-K · filed 2025-03-07 | |||
| 2024-09-30 | $500.00K 10-Q · filed 2024-11-06 | $3.30M 10-Q · filed 2024-11-06 | ||
| 2024-06-30 | $2.00M 10-Q · filed 2024-08-06 | $2.70M 10-Q · filed 2024-08-06 | ||
| 2024-03-31 | $700.00K 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $2.60M 10-K · filed 2025-03-07 | |||
| 2023-09-30 | $400.00K 10-Q · filed 2024-11-06 | $2.20M 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | $900.00K 10-Q · filed 2024-08-06 | $1.80M 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $900.00K 10-Q · filed 2024-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |